Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Cytomegalovirus-Seronegative Plus Leukoreduced Blood Products Are Still Superior to Only Leukoreduced Products in Preventing Transfusion-Transmitted Cytomegalovirus Infection

Kimikazu Yakushijin, Ryu Yanagisawa, Sachiko Seo, Masao Ogata, Michiko Kajiwara, Naoyuki Uchida, Youko Suehiro, Noriko Doki, Daiichiro Hasegawa, Satoshi Yoshihara, Kensuke Usuki, Katsuyoshi Koh, Yoshinobu Kanda, Mineo Kurokawa, Makoto Onizuka, Fumihiko Ishimaru, Yoshiko Atsuta, Takahiro Fukuda, Hideki Nakasone

Blood (2023) 142 (Supplement 1): 2666.

https://doi.org/10.1182/blood-2023-178182

Published: 2023

Journal Articles

A Phase I/II Clinical Trial of Piggybac -Modified GMR CAR-T Cell Therapy for CD116 Positive Relapsed/Refractory Myeloid Malignancies

Shoji Saito, Miyuki Tanaka, Aiko Hasegawa, Yoichi Inada, Hirokazu Morokawa, Yoko Usami, Shunsuke Kojima, Ryu Yanagisawa, Chinatsu Miyazawa, Keiko Ito, Hitoshi Sakai, Hideyuki Nakazawa, Haruko Tashiro, Shigeki Yagyu, Yozo Nakazawa

Blood (2021) 138 (Supplement 1): 4813.

https://doi.org/10.1182/blood-2021-149089

Published: 2021

Journal Articles

Predictive Factors of the Development of Leukemia in Patients with Transient Abnormal Myelopoiesis and Down Syndrome: The Jccg Study JPLSG TAM-10

Blood (2019) 134 (Supplement_1): 3833.

https://doi.org/10.1182/blood-2019-125465

Published: 2019

Journal Articles

Analysis of GATA1 Mutations in Down Syndrome Infants with Transient Abnormal Myelopoiesis and Clinical Impacts of GATA1 Mutation Types: A Report from the JPLSG TAM-10 Study

Kiminori Terui, MD PhD, Tsutomu Toki, PhD, Asahito Hama, MD PhD, Hideki Muramatsu, MD PhD, Daisuke Hasegawa, MD PhD, Myoung-Ja Park, MD PhD, Shotaro Iwamoto, MD PhD, Takashi Taga, MD PhD, Ryu Yanagisawa, MD PhD, Katsuyoshi Koh, MD, Akiko M. Saito, MD PhD, Keizo Horibe, MD PhD, Yasuhide Hayashi, MD PhD, Souichi Adachi, MD, PhD, Shuki Mizutani, MD, PhD, Kenichiro Watanabe, MD PhD, Etsuro Ito, MD PhD

Blood (2016) 128 (22): 2865.

https://doi.org/10.1182/blood.V128.22.2865.2865

Published: 2016

Journal Articles

Deformation of erythroblasts in transient erythroblastopenia of childhood caused by HHV-6

Akira Ogawa, Ryu Yanagisawa

Blood (2016) 127 (22): 2776.

https://doi.org/10.1182/blood-2016-03-704924

Published: 2016

Journal Articles

Prospective Study of 168 Infants with Transient Abnormal Myelopoiesis with Down Syndrome: Japan Pediatric Leukemia/Lymphoma Study Group, TAM-10 Study

Hideki Muramatsu, MD PhD, Tomoyuki Watanabe, Daisuke Hasegawa, MD PhD, Park Myoung-ja, Shotaro Iwamoto, Takashi Taga, MD PhD, Etsuro Ito, MD PhD, Tsutomu Toki, PhD, Kiminori Terui, Ryu Yanagisawa, Katsuyoshi Koh, MD PhD, Akiko M. Saito, Keizo Horibe, MD PhD, Yasuhide Hayashi, MD PhD, Souichi Adachi, MD PhD, Shuki Mizutani, MD PhD, Kenichiro Watanabe

Blood (2015) 126 (23): 1311.

https://doi.org/10.1182/blood.V126.23.1311.1311

Published: 2015

Journal Articles

Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations

Kazuyuki Matsuda, Chiaki Taira, Kazuo Sakashita, Shoji Saito, Miyuki Tanaka-Yanagisawa, Ryu Yanagisawa, Yozo Nakazawa, Masaaki Shiohara, Keitaro Fukushima, Megumi Oda, Takayuki Honda, Tatsutoshi Nakahata, Kenichi Koike

Blood (2010) 115 (26): 5429–5431.

https://doi.org/10.1182/blood-2009-12-260729

Published: 2010

Journal Articles

Mutations in Ribosomal Protein Genes of Diamond-Blackfan Anemia Patients in Japan.

Yuki Konno, MD, Tsutomu Toki, PhD, Satoru Tandai, MD, PhD, Gang Xu, MD, PhD, Kiminori Terui, MD, PhD, Shouichi Ohga, MD, PhD, Seiji Kojima, MD, PhD, Ryu Yanagisawa, MD, PhD, Kenichi Koike, MD, PhD, Daiichiro Hasegawa, MD.PhD, Yoshiyuki Kosaka, MD.PhD, Rie Kanei, MD.PhD, Tsuyoshi Imai, MD, PhD, Teruaki Hongo, MD, PhD, Myoung-Ja Park, MD.PhD, Arata Watanabe, MD, PhD, Etsuro Ito, MD, PhD

Blood (2009) 114 (22): 3204.

https://doi.org/10.1182/blood.V114.22.3204.3204

Published: 2009

Journal Articles

Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations

Blood (2007) 109 (12): 5477–5480.

https://doi.org/10.1182/blood-2006-09-046649

Published: 2007

NARROW

Cytomegalovirus-Seronegative Plus Leukoreduced Blood Products Are Still Superior to Only Leukoreduced Products in Preventing Transfusion-Transmitted Cytomegalovirus Infection

A Phase I/II Clinical Trial of Piggybac -Modified GMR CAR-T Cell Therapy for CD116 Positive Relapsed/Refractory Myeloid Malignancies

Predictive Factors of the Development of Leukemia in Patients with Transient Abnormal Myelopoiesis and Down Syndrome: The Jccg Study JPLSG TAM-10

Analysis of GATA1 Mutations in Down Syndrome Infants with Transient Abnormal Myelopoiesis and Clinical Impacts of GATA1 Mutation Types: A Report from the JPLSG TAM-10 Study

Deformation of erythroblasts in transient erythroblastopenia of childhood caused by HHV-6

Prospective Study of 168 Infants with Transient Abnormal Myelopoiesis with Down Syndrome: Japan Pediatric Leukemia/Lymphoma Study Group, TAM-10 Study

Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations

Mutations in Ribosomal Protein Genes of Diamond-Blackfan Anemia Patients in Japan.

Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only